Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Prebiotic milk oligosaccharides (MO) are complex sugars that selectively enhance the growth of Bifidobacterium infantis (B. infantis). The current study examines the effects of bovine MO and B. infantis in preventing non-alcoholic steatohepatitis (NASH) in Western diet (WD)-fed bile acid (BA) receptor FXR (farnesoid × receptor) knockout (KO) mice. WD-fed FXR KO mice, which have cancer-prone NASH and reduced B. infantis, were supplemented with B. infantis, MO, and combination of both. Two months intervention by B. infantis and/or MO improved insulin sensitivity. In addition, all 3 treatments reduced expression of pro-inflammatory genes in the liver and ileum. Consistently, 7 months treatment reduced hepatic lymphocyte infiltration in WD-fed FXR KO mice. In addition, B. infantis, but not MO, decreased hepatic triglyceride and cholesterol. A combination of both further reduced hepatic cholesterol, the precursor of BAs, but not hepatic triglyceride. All three treatments modulated hepatic and serum BA profile by reducing deoxycholic acid, hyodeoxycholic acid and increasing chenodeoxycholic acid as well as ursodeoxycholic acid level. In addition, B. infantis and MO decreased hepatic CYP7A1 and increased the expression of Sult2a1, Sult2a2, and Sult2a3 suggesting decreased BA synthesis and increased detoxification. Furthermore, B. infantis and MO increased ileal BA membrane receptor TGR5 as well as Glp1r, PC1/3, and Nos3 suggesting increased TGR5-regulated signaling. Moreover, MO alone, but not B. infantis, could increase the abundance of butyrate-generating bacterium that has beneficial effect in NASH treatment. Together, B. infantis and MO have their unique and combined effects in reversing NASH in WD-fed FXR KO mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885 · cited 1×
“Activation of TGR5 protects intestinal barrier function, reduces inflammation, improves insulin sensitivity, and stimulates GLP-1 secretion [67, 68].”
BackgroundTargeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819 · cited 1×
“Specific pathogen-free C57BL/6 wild type (WT) mice (Jackson Laboratory, Sacramento, CA, USA) as well as age- and sex-matched FXR KO mice [33] were housed in steel microisolator cages at 22°C with a 12-hour light/dark cycle.”
MethodA G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 14×
“Another TGR5 ligand, hepatic lithocholic acid (LCA) was increased by B. infantis and a combination of B. infantis plus MO.”
BackgroundInfluentialRegulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 1×
“Activation of farnesoid × receptor (FXR) by BAs, protects the distal small intestine from bacterial invasion and overgrowth in bile duct ligation in mouse models [20].”
BackgroundFat, fibre and cancer risk in African Americans and rural Africans
O’Keefe, S. J. D., Li, J. V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J. M., Kinross, J., Wahl, E., Ruder, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms7342 · Cited by 982
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693
Ou, J., Carbonero, F., Zoetendal, E. G., DeLany, J. P., Wang, M., Newton, K., Gaskins, H. R., & O’Keefe, S. J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.056689 · Cited by 646
Pathak, P., Xie, C., Nichols, R. G., Ferrell, J. M., Boehme, S., Krausz, K. W., Patterson, A. D., Gonzalez, F. J., & Chiang, J. Y. L. (2018) · Hepatology · doi:10.1002/hep.29857 · Cited by 567 · cited 1×
“In addition, LCA is a potent pregnane × receptor (PXR) agonist, and induce BAspecific sulfotransferase 2 (Sult2) family to conjugate sulfur to LCA for renal and fecal excretion [73, 74].”
BackgroundYang, F., Huang, X., Yi, T., Yen, Y., Moore, D. D., & Huang, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1078 · Cited by 488
Cited by
Dysbiosis of the Gut Microbiome Is Associated With Tumor Biomarkers in Lung Cancer
Liu, F., Li, J., Guan, Y., Lou, Y., Chen, H., Xu, M., Deng, D., Chen, J., Ni, B., Zhao, L., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.35980 · Cited by 197
Ma, J., Hong, Y., Zheng, N., Xie, G., Lyu, Y., Gu, Y., Xi, C., Chen, L., Wu, G., Li, Y., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1763770 · Cited by 171
“The degree of hepatic lymphocyte infiltration was evaluated according to a previous publication in a blinded way.(29) The criteria for scoring including 0 (absent), 1 (rare), 2 (mild), 3 (moderate), and 4 (severe).”
MethodSelf-citationYu, H.-H., Hsieh, M.-C., Wu, S.-Y., Sy, E. D., & Shan, Y.-S. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s190631 · Cited by 9
“They found that both synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone NASH using Western diet-fed FXR KO mice.(34) In this study, we did not assess the effects of DJB on the alterations of incretin hormones and genetic expression.”
Method
Metadata
- Authors
- Jena, P. K., Sheng, L., Nagar, N., Wu, C., Barile, D., Mills, D. A., & Wan, Y.-J. Y.
- Venue
- The Journal of Nutritional Biochemistry
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 57
- Pages
- 246-254
- ISSN
- 0955-2863 (ISSN-L)
- OpenAlex
- W2802792185
- Cited by
- 60
- References
- 21
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.